The chemical class known as Usf3 Inhibitors encompasses a collection of compounds that indirectly influence USF3, a transcription factor implicated in the regulation of gene expression. The compounds listed do not directly interact with USF3; instead, they modulate various cellular mechanisms and pathways that can alter the transcriptional landscape within which USF3 operates. For instance, histone acetylation and DNA methylation are crucial for chromatin organization and gene expression regulation. Compounds such as Trichostatin A, 5-Azacytidine, and RG108 can modify the epigenetic state by inhibiting histone deacetylases and DNA methyltransferases, respectively. These changes in the epigenetic profile can affect the binding of USF3 to DNA and its subsequent transcriptional activity.
Other compounds, like Mithramycin A, influence DNA-protein interactions, which may impact USF3's ability to regulate gene expression. Chloroquine, JQ1, and I-BET762 perturb cellular signaling and chromatin structure. Chloroquine disrupts lysosomal function, which can have widespread effects on cellular signaling pathways, including those that involve transcription factors. JQ1 and I-BET762 target bromodomain-containing proteins, altering the expression of genes in a manner that can indirectly affect USF3's function. Similarly, C646, Garcinol, and SGC-CBP30 are inhibitors of enzymes responsible for histone modifications, which can have an impact on USF3's interaction with chromatin and its transcriptional regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylases, leading to increased acetylation of histones and potentially affecting USF3 binding to chromatin. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Inhibits DNA methyltransferases, resulting in hypomethylation of DNA and changes in gene expression that can affect USF3's regulatory scope. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
Another DNA methyltransferase inhibitor, alters methylation patterns, leading to changes in the transcriptional landscape where USF3 operates. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to GC-rich DNA sequences, possibly preventing USF3 from accessing its DNA binding sites. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Interferes with lysosomal function and autophagy, potentially affecting USF3-related signaling pathways. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Disrupts BET bromodomain protein interactions with acetylated histones, altering gene expression in a way that can affect USF3. | ||||||
GSK 525762A | 1260907-17-2 | sc-490339 sc-490339A sc-490339B sc-490339C sc-490339D | 5 mg 10 mg 50 mg 100 mg 1 g | $300.00 $540.00 $940.00 $1680.00 $5900.00 | ||
BET bromodomain inhibitor, changes transcriptional regulation and could impact USF3's activity. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
Inhibits p300 histone acetyltransferase, impacting acetylation levels of histones and possibly affecting USF3-mediated transcription. | ||||||
Garcinol | 78824-30-3 | sc-200891 sc-200891A | 10 mg 50 mg | $124.00 $502.00 | 13 | |
Inhibits p300/CBP histone acetyltransferase, potentially altering USF3's interaction with chromatin due to changes in acetylation. | ||||||
SGC-CBP30 | 1613695-14-9 | sc-473871 sc-473871A | 5 mg 10 mg | $178.00 $338.00 | ||
A CBP/p300 bromodomain inhibitor, can change chromatin accessibility and influence USF3's transcriptional activity. | ||||||